A detailed history of Fmr LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 4,780,563 shares of EWTX stock, worth $163 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,780,563
Previous 6,365,724 24.9%
Holding current value
$163 Million
Previous $116 Million 25.85%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$15.08 - $21.23 $23.9 Million - $33.7 Million
-1,585,161 Reduced 24.9%
4,780,563 $86.1 Million
Q1 2024

May 13, 2024

SELL
$9.25 - $19.97 $1.17 Million - $2.53 Million
-126,789 Reduced 1.95%
6,365,724 $116 Million
Q4 2023

Feb 13, 2024

BUY
$5.51 - $12.1 $494,059 - $1.08 Million
89,666 Added 1.4%
6,492,513 $71 Million
Q3 2023

Nov 13, 2023

SELL
$5.73 - $7.69 $5.47 Million - $7.34 Million
-954,642 Reduced 12.98%
6,402,847 $36.7 Million
Q2 2023

Aug 11, 2023

SELL
$5.71 - $10.29 $3.33 Million - $6 Million
-583,053 Reduced 7.34%
7,357,489 $57 Million
Q1 2023

May 11, 2023

SELL
$6.66 - $11.33 $4.32 Million - $7.35 Million
-648,687 Reduced 7.55%
7,940,542 $53 Million
Q4 2022

Feb 13, 2023

BUY
$7.58 - $11.08 $4.64 Million - $6.79 Million
612,416 Added 7.68%
8,589,229 $76.8 Million
Q3 2022

Nov 10, 2022

BUY
$8.08 - $13.58 $41.7 Million - $70.1 Million
5,161,529 Added 183.34%
7,976,813 $78.5 Million
Q2 2022

Aug 12, 2022

BUY
$5.67 - $9.87 $1.67 Million - $2.9 Million
293,834 Added 11.65%
2,815,284 $22.4 Million
Q1 2022

May 13, 2022

BUY
$9.1 - $18.97 $194,294 - $405,028
21,351 Added 0.85%
2,521,450 $24.5 Million
Q4 2021

Feb 14, 2022

SELL
$14.41 - $22.41 $9.43 Million - $14.7 Million
-654,573 Reduced 20.75%
2,500,099 $38.2 Million
Q3 2021

Nov 15, 2021

BUY
$14.11 - $24.1 $10.4 Million - $17.8 Million
739,454 Added 30.62%
3,154,672 $52.4 Million
Q2 2021

Aug 13, 2021

BUY
$21.33 - $30.25 $51.5 Million - $73.1 Million
2,415,218 New
2,415,218 $51.5 Million

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $2.15B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.